| Date | Company Name | Action | Current
Price | Price
Target | Rating |
|---|
| 5/1/2026 | STRO Sutro Biopharma | Upgrade | $36.00 | | Strong-Buy |
| 4/24/2026 | INBX Inhibrx Biosciences | Upgrade | $129.00 | | Strong-Buy |
| 4/6/2026 | SLNO Soleno Therapeutics | Downgrade | $53.00 | | Strong-Buy ➝ Hold |
| 4/1/2026 | CNTA Centessa Pharmaceuticals | Downgrade | $40.00 | | Strong-Buy ➝ Hold |
| 3/31/2026 | MBX MBX Biosciences | Upgrade | $30.00 | | Strong-Buy |
| 3/19/2026 | MREO Mereo BioPharma Group | Upgrade | $0.00 | | Hold |
| 3/16/2026 | TARS Tarsus Pharmaceuticals | Upgrade | $64.00 | | Strong-Buy |
| 3/12/2026 | TENX Tenax Therapeutics | Upgrade | $13.00 | | Strong-Buy |
| 3/6/2026 | JBIO Jade Biosciences | Upgrade | $24.00 | | Strong-Buy |
| 3/5/2026 | LQDA Liquidia | Upgrade | $38.00 | | Strong-Buy |
| 3/5/2026 | TNYA Tenaya Therapeutics | Upgrade | $1.00 | | Strong-Buy |
| 3/2/2026 | PRME Prime Medicine | Upgrade | $3.00 | | Strong-Buy |
| 2/26/2026 | RCKT Rocket Pharmaceuticals | Upgrade | $4.00 | | Strong-Buy |
| 2/25/2026 | SION Sionna Therapeutics | Upgrade | $39.00 | | Strong-Buy |
| 2/24/2026 | LRMR Larimar Therapeutics | Upgrade | $4.00 | | Strong-Buy |
| 2/23/2026 | CNTX Context Therapeutics | Upgrade | $2.00 | | Strong-Buy |
| 2/23/2026 | IKT Inhibikase Therapeutics | Upgrade | $2.00 | | Strong-Buy |
| 2/13/2026 | CRNX Crinetics Pharmaceuticals | Upgrade | $39.00 | | Strong-Buy |
| 2/12/2026 | CMPS Compass Pathways | Upgrade | $9.00 | | Strong-Buy |
| 2/12/2026 | IRD Opus Genetics | Upgrade | $5.00 | | Strong-Buy |
| 2/5/2026 | TECX Tectonic Therapeutic | Upgrade | $29.00 | | Strong-Buy |
| 2/2/2026 | DMRA Damora Therapeutics, Inc. Common Stock | Upgrade | $25.00 | | Strong-Buy |
| 1/26/2026 | NGNE Neurogene | Initiated Coverage | $27.00 | $50.00 | Outperform |
| 12/29/2025 | MREO Mereo BioPharma Group | Downgrade | $0.00 | | Outperform ➝ Hold |
| 12/23/2025 | SION Sionna Therapeutics | Initiated Coverage | $39.00 | $60.00 | Outperform |
| 12/23/2025 | PRME Prime Medicine | Upgrade | $3.00 | | Strong-Buy |
| 12/23/2025 | PRME Prime Medicine | Initiated Coverage | $3.00 | $6.00 | Outperform |
| 12/22/2025 | OVID Ovid Therapeutics | Initiated Coverage | $3.00 | $4.00 | Outperform |
| 12/18/2025 | MAZE Maze Therapeutics | Upgrade | $27.00 | | Strong-Buy |
| 12/18/2025 | IBIO iBio | Upgrade | $2.00 | | Strong-Buy |
| 12/11/2025 | EPRX Eupraxia Pharmaceuticals | Upgrade | $8.00 | | Strong-Buy |
| 12/3/2025 | OCS Oculis | Initiated Coverage | $27.00 | $55.00 | Outperform |
| 12/2/2025 | UPB Upstream Bio | Initiated Coverage | $9.00 | $43.00 | Outperform |
| 12/1/2025 | IKT Inhibikase Therapeutics | Upgrade | $2.00 | | Strong-Buy |
| 11/14/2025 | ADAG Adagene | Upgrade | $4.00 | | Strong-Buy |
| 11/13/2025 | SRZN Surrozen | Upgrade | $34.00 | | Strong-Buy |
| 11/13/2025 | KLC KinderCare Learning Companies | Reiterated Rating | $4.00 | | Market Perform |
| 10/27/2025 | AMLX Amylyx Pharmaceuticals | Upgrade | $16.00 | | Strong-Buy |
| 10/23/2025 | KOD Kodiak Sciences | Initiated Coverage | $44.00 | $40.00 | Outperform |
| 10/21/2025 | CADL Candel Therapeutics | Initiated Coverage | $6.00 | $16.00 | Outperform |
| 10/14/2025 | DYN Dyne Therapeutics | Upgrade | $17.00 | | Strong-Buy |
| 10/14/2025 | DFTX Definium Therapeutics | Upgrade | $22.00 | | Strong-Buy |
| 10/14/2025 | SVRA Savara | Upgrade | $5.00 | | Strong-Buy |
| 10/6/2025 | CMPX Compass Therapeutics | Initiated Coverage | $2.00 | $10.00 | Outperform |
| 9/29/2025 | KALA KALA BIO | Downgrade | $0.00 | | Strong-Buy ➝ Hold |
| 9/10/2025 | SLNO Soleno Therapeutics | Upgrade | $53.00 | | Strong-Buy |
| 9/8/2025 | GPCR Structure Therapeutics | Upgrade | $42.00 | | Strong-Buy |
| 9/3/2025 | PRAX Praxis Precision Medicines | Upgrade | $324.00 | | Strong-Buy |
| 9/3/2025 | CNTA Centessa Pharmaceuticals | Upgrade | $40.00 | | Strong-Buy |
| 9/3/2025 | KALA KALA BIO | Upgrade | $0.00 | | Strong-Buy |
| 9/3/2025 | AQST Aquestive Therapeutics | Upgrade | $4.00 | | Strong-Buy |
| 8/18/2025 | RVMD Revolution Medicines | Initiated Coverage | $139.00 | $80.00 | Outperform |
| 8/4/2025 | PVLA Palvella Therapeutics | Initiated Coverage | $127.00 | $90.00 | Outperform |
| 7/30/2025 | VYNE VYNE Therapeutics | Downgrade | $1.00 | | Strong-Buy ➝ Hold |
| 7/23/2025 | ABVX Abivax | Boost Price Target | $118.00 | $45.00 ➝ $101.00 | Outperform ➝ Outperform |
| 7/12/2025 | CRBP Corbus Pharmaceuticals | Upgrade | $10.00 | | Strong-Buy |
| 7/12/2025 | CATX Perspective Therapeutics | Upgrade | $4.00 | | Strong-Buy |
| 6/26/2025 | DBVT DBV Technologies | Upgrade | $20.00 | | Strong-Buy |
| 6/18/2025 | CBIO Crescent Biopharma | Upgrade | $18.00 | $22.00 | Strong-Buy |
| 6/6/2025 | TECX Tectonic Therapeutic | Initiated Coverage | $29.00 | $87.00 | Outperform |
| 6/5/2025 | TECX Tectonic Therapeutic | Upgrade | $29.00 | | Strong-Buy |
| 6/3/2025 | SRRK Scholar Rock | Upgrade | $46.00 | | Strong-Buy |
| 3/12/2025 | GLUE Monte Rosa Therapeutics | Initiated Coverage | $19.00 | $19.00 | Outperform |
| 3/11/2025 | ZYME Zymeworks | Initiated Coverage | $27.00 | $30.00 | Outperform |
| 3/11/2025 | IMNM Immunome | Initiated Coverage | $23.00 | $20.00 | Outperform |
| 3/11/2025 | TARA Protara Therapeutics | Initiated Coverage | $5.00 | $22.00 | Outperform |
| 3/11/2025 | MOLN Molecular Partners | Initiated Coverage | $4.00 | $12.00 | Outperform |
| 3/6/2025 | CATX Perspective Therapeutics | Upgrade | $4.00 | | Strong-Buy |
| 2/4/2025 | SLNO Soleno Therapeutics | Upgrade | $53.00 | | Strong-Buy |
| 1/31/2025 | AURA Aura Biosciences | Upgrade | $7.00 | | Strong-Buy |
| 12/27/2024 | JANX Janux Therapeutics | Upgrade | $14.00 | | Strong-Buy |
| 12/24/2024 | MREO Mereo BioPharma Group | Initiated Coverage | $0.00 | $10.00 | Outperform |
| 12/23/2024 | MREO Mereo BioPharma Group | Upgrade | $0.00 | | Strong-Buy |
| 10/22/2024 | KURA Kura Oncology | Upgrade | $9.00 | | Strong-Buy |
| 10/10/2024 | OKUR OnKure Therapeutics | Upgrade | $5.00 | | Strong-Buy |
| 10/3/2024 | LQDA Liquidia | Initiated Coverage | $38.00 | $30.00 | Outperform |
| 10/2/2024 | LQDA Liquidia | Upgrade | $38.00 | | Strong-Buy |
| 9/16/2024 | ORKA Oruka Therapeutics | Initiated Coverage | $63.00 | $41.00 | Outperform |
| 9/9/2024 | AURA Aura Biosciences | Upgrade | $7.00 | | Strong-Buy |
| 8/26/2024 | CELC Celcuity | Initiated Coverage | $126.00 | $27.00 | Outperform |
| 8/21/2024 | CRBP Corbus Pharmaceuticals | Upgrade | $10.00 | | Strong-Buy |
| 7/31/2024 | ALXO ALX Oncology | Downgrade | $2.00 | | Strong-Buy ➝ Hold |
| 7/29/2024 | NUVL Nuvalent | Upgrade | $99.00 | | Strong-Buy |
| 7/29/2024 | IDYA IDEAYA Biosciences | Upgrade | $28.00 | | Strong-Buy |
| 6/11/2024 | DNTH Dianthus Therapeutics | Upgrade | $87.00 | | Strong-Buy |
| 5/28/2024 | CALT Calliditas Therapeutics AB (publ) | Downgrade | $40.00 | | Strong-Buy ➝ Hold |
| 5/6/2024 | CATX Perspective Therapeutics | Reiterated Rating | $4.00 | | Outperform |
| 3/26/2024 | MLYS Mineralys Therapeutics | Reiterated Rating | $29.00 | | Outperform |
| 2/27/2024 | GPCR Structure Therapeutics | Reiterated Rating | $42.00 | | Outperform |
| 2/20/2024 | LRMR Larimar Therapeutics | Reiterated Rating | $4.00 | | Outperform |
| 1/23/2024 | INBX Inhibrx Biosciences | Downgrade | $129.00 | | Outperform ➝ Market Perform |
| 1/5/2024 | IVA Inventiva | Reiterated Rating | $5.00 | | Outperform |
| 12/26/2023 | TARS Tarsus Pharmaceuticals | Reiterated Rating | $64.00 | | Outperform |
| 12/26/2023 | RCKT Rocket Pharmaceuticals | Reiterated Rating | $4.00 | | Outperform |
| 12/4/2023 | SYRE Spyre Therapeutics | Reiterated Rating | $69.00 | | Outperform |
| 11/27/2023 | TCRX TScan Therapeutics | Reiterated Rating | $1.00 | | Outperform |
| 8/8/2023 | INBX Inhibrx Biosciences | Reiterated Rating | $129.00 | | Outperform |
| 8/8/2023 | TNYA Tenaya Therapeutics | Reiterated Rating | $1.00 | | Outperform |
| 5/22/2023 | RAIN Rain Enhancement Technologies Holdco | Downgrade | $2.00 | | Outperform ➝ Market Perform |
